Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Profit After Tax (2018 - 2025)

Neurogene (NGNE) has disclosed Profit After Tax for 5 consecutive years, with -$20.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Profit After Tax fell 2.83% year-over-year to -$20.9 million, compared with a TTM value of -$85.1 million through Sep 2025, down 46.7%, and an annual FY2024 reading of -$75.1 million, down 107.01% over the prior year.
  • Profit After Tax was -$20.9 million for Q3 2025 at Neurogene, up from -$22.0 million in the prior quarter.
  • Across five years, Profit After Tax topped out at -$16.9 million in Q1 2024 and bottomed at -$22.6 million in Q1 2025.